FDA Inspection 1057479 — Anne-Sofie Krogsaa, MD

Anne-Sofie Krogsaa, MD — FEI 3014290881

The FDA completed an inspection of Anne-Sofie Krogsaa, MD on Jun 14, 2018 in Ballerup. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ballerup (Denmark)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.